Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-06-06 @ 8:13 PM
Study NCT ID:
NCT07447050
Status:
RECRUITING
Last Update Posted:
2026-03-03
First Post:
2026-02-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Sponsor:
University of California, Irvine
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
| None | Sarcoma | View |
| None | Gastric (Stomach) Cancer | View |
| None | Lung Cancer | View |
| None | Head and Neck Cancer | View |
| None | Colorectal Cancer | View |
| None | Ovarian Cancer | View |
| None | Liver Cancer | View |
| None | Genitourinary Cancer | View |
| None | Gynecologic Cancer | View |
Keywords: